Sigachi Industries [SIGACHI] vs Windlas Biotech [WINDLAS] Detailed Stock Comparison
Sigachi Industries
NSE
Loading...
Windlas Biotech
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Sigachi Industries wins in 8 metrics, Windlas Biotech wins in 12 metrics, with 0 ties. Windlas Biotech appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Sigachi Industries | Windlas Biotech | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 18.82 | 29.48 | Sigachi Industries |
| Price-to-Book Ratio | 2.43 | 3.75 | Sigachi Industries |
| Debt-to-Equity Ratio | 23.21 | 6.45 | Windlas Biotech |
| PEG Ratio | -0.02 | 0.97 | Sigachi Industries |
| EV/EBITDA | 15.36 | 16.52 | Sigachi Industries |
| Profit Margin (TTM) | -8.44% | 8.20% | Windlas Biotech |
| Operating Margin (TTM) | 15.11% | 9.08% | Sigachi Industries |
| EBITDA Margin (TTM) | 15.11% | 9.08% | Sigachi Industries |
| Return on Equity | 11.35% | 12.06% | Windlas Biotech |
| Return on Assets (TTM) | 8.22% | 8.02% | Sigachi Industries |
| Free Cash Flow (TTM) | $-163.98M | $159.93M | Windlas Biotech |
| Dividend Yield | 0.23% | 1.23% | Windlas Biotech |
| 1-Year Return | -25.72% | 6.36% | Windlas Biotech |
| Price-to-Sales Ratio (TTM) | 2.90 | 2.39 | Windlas Biotech |
| Enterprise Value | $15.93B | $16.95B | Windlas Biotech |
| EV/Revenue Ratio | 3.06 | 2.13 | Windlas Biotech |
| Gross Profit Margin (TTM) | 51.03% | 38.25% | Sigachi Industries |
| Revenue per Share (TTM) | $15 | $380 | Windlas Biotech |
| Earnings per Share (Diluted) | $-0.98 | $30.73 | Windlas Biotech |
| Beta (Stock Volatility) | 0.41 | 0.28 | Windlas Biotech |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Sigachi Industries vs Windlas Biotech Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Sigachi Industries | 1.36% | 5.33% | 26.04% | -4.20% | 4.42% | -20.51% |
| Windlas Biotech | -0.06% | 1.89% | -4.05% | 4.32% | -7.70% | -9.95% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Sigachi Industries | -25.72% | -85.55% | -92.93% | -92.93% | -92.93% | -92.93% |
| Windlas Biotech | 6.36% | 286.10% | 156.38% | 156.38% | 156.38% | 156.38% |
News Based Sentiment: Sigachi Industries vs Windlas Biotech
Sigachi Industries
News based Sentiment: NEGATIVE
September brought a series of challenges for Sigachi Industries, including disappointing financial results, a substantial net loss due to a tragic factory incident, and mixed analyst opinions. While institutional investment provided some support, the overall narrative points to significant operational and financial headwinds, making it a critical month for the company's future.
Windlas Biotech
News based Sentiment: POSITIVE
Windlas Biotech delivered strong Q1 FY26 results with significant revenue and profit growth, coupled with strategic initiatives focused on expansion and plant refurbishment. This positive performance, combined with continued investor engagement, suggests a favorable outlook for the company and its stock.
Performance & Financial Health Analysis: Sigachi Industries vs Windlas Biotech
| Metric | SIGACHI | WINDLAS |
|---|---|---|
| Market Information | ||
| Market Cap | ₹15.12B | ₹19.00B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 11,054,762 | 37,599 |
| 90 Day Avg. Volume | 26,532,407 | 39,334 |
| Last Close | ₹40.12 | ₹940.15 |
| 52 Week Range | ₹30.51 - ₹59.59 | ₹665.10 - ₹1,198.25 |
| % from 52W High | -32.67% | -21.54% |
| All-Time High | ₹634.00 (Nov 15, 2021) | ₹1,198.25 (Nov 04, 2024) |
| % from All-Time High | -93.67% | -21.54% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.34% | 0.20% |
| Quarterly Earnings Growth | N/A | 0.31% |
| Financial Health | ||
| Profit Margin (TTM) | -0.08% | 0.08% |
| Operating Margin (TTM) | 0.15% | 0.09% |
| Return on Equity (TTM) | 0.11% | 0.12% |
| Debt to Equity (MRQ) | 23.21 | 6.45 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹16.31 | ₹241.38 |
| Cash per Share (MRQ) | ₹1.89 | ₹114.20 |
| Operating Cash Flow (TTM) | ₹498.99M | ₹396.84M |
| Levered Free Cash Flow (TTM) | ₹695.63M | ₹609.94M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.23% | 1.23% |
| Last 12-Month Dividend | ₹0.10 | ₹11.30 |
Valuation & Enterprise Metrics Analysis: Sigachi Industries vs Windlas Biotech
| Metric | SIGACHI | WINDLAS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 18.82 | 29.48 |
| Forward P/E | N/A | N/A |
| PEG Ratio | -0.02 | 0.97 |
| Price to Sales (TTM) | 2.90 | 2.39 |
| Price to Book (MRQ) | 2.43 | 3.75 |
| Market Capitalization | ||
| Market Capitalization | ₹15.12B | ₹19.00B |
| Enterprise Value | ₹15.93B | ₹16.95B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.06 | 2.13 |
| Enterprise to EBITDA | 15.36 | 16.52 |
| Risk & Other Metrics | ||
| Beta | 0.41 | 0.28 |
| Book Value per Share (MRQ) | ₹16.31 | ₹241.38 |
Financial Statements Comparison: Sigachi Industries vs Windlas Biotech
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SIGACHI | WINDLAS |
|---|---|---|
| Revenue/Sales | ₹1.28B | ₹2.10B |
| Cost of Goods Sold | ₹627.97M | ₹1.30B |
| Gross Profit | ₹654.50M | ₹803.60M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹193.77M | ₹190.76M |
| EBITDA | ₹280.45M | ₹317.63M |
| Pre-Tax Income | ₹-1.01B | ₹232.57M |
| Income Tax | ₹-221,000 | ₹55.93M |
| Net Income (Profit) | ₹-1.01B | ₹176.64M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SIGACHI | WINDLAS |
|---|---|---|
| Cash & Equivalents | ₹172.62M | ₹4.24M |
| Total Current Assets | ₹3.94B | ₹5.25B |
| Total Current Liabilities | ₹1.85B | ₹2.49B |
| Long-Term Debt | ₹216.14M | ₹22.51M |
| Total Shareholders Equity | ₹6.13B | ₹5.06B |
| Retained Earnings | ₹2.39B | ₹2.75B |
| Property, Plant & Equipment | ₹20.84M | ₹2.19B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SIGACHI | WINDLAS |
|---|---|---|
| Operating Cash Flow | ₹-7.48M | N/A |
| Capital Expenditures | ₹-31.96M | N/A |
| Free Cash Flow | ₹-28.47M | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SIGACHI | WINDLAS |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 11,054,762 | 37,599 |
| Average Daily Volume (90 Day) | 26,532,407 | 39,334 |
| Shares Outstanding | 382.12M | 20.96M |
| Float Shares | 215.22M | 7.57M |
| % Held by Insiders | 0.51% | 0.65% |
| % Held by Institutions | 0.00% | 0.09% |
Dividend Analysis & Yield Comparison: Sigachi Industries vs Windlas Biotech
| Metric | SIGACHI | WINDLAS |
|---|---|---|
| Last 12-Month Dividend | ₹0.10 | ₹11.30 |
| Last 12-Month Dividend Yield | 0.23% | 1.23% |
| 3-Year Avg Annual Dividend | ₹0.07 | ₹6.27 |
| 3-Year Avg Dividend Yield | 0.13% | 0.96% |
| 3-Year Total Dividends | ₹0.21 | ₹18.80 |
| Ex-Dividend Date | Sep 16, 2025 | Jul 21, 2025 |